Illumina (ILMN) SEC Filings: History & Chart

Illumina, Inc.(ILMN)

Medical - Diagnostics & Research · San Diego, CA

$273.04+7.32 (+2.75%)

Delayed quote: Oct 2, 2026, 4:00 PM EDT

About Illumina, Inc.

Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific. Additionally, it partners with life-science distributors to reach markets in Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.

San Diego, CA

8,600 employees

www.illumina.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Jacob Thaysen

View full financials

Form	Filing Date	Accepted	Document
4	Sep 10, 2026	Sep 10, 2026	View filing
4	Sep 9, 2026	Sep 9, 2026	View filing
4	Sep 4, 2026	Sep 4, 2026	View filing
4	Aug 27, 2026	Aug 27, 2026	View filing
4	Aug 21, 2026	Aug 21, 2026	View filing
4	Aug 20, 2026	Aug 20, 2026	View filing
8-K	Aug 17, 2026	Aug 17, 2026	View filing
8-K	Aug 13, 2026	Aug 13, 2026	View filing
424B2	Aug 12, 2026	Aug 12, 2026	View filing
8-K	Aug 12, 2026	Aug 12, 2026	View filing
3	Aug 11, 2026	Aug 11, 2026	View filing
FWP	Aug 10, 2026	Aug 10, 2026	View filing
424B2	Aug 10, 2026	Aug 10, 2026	View filing
4	Aug 7, 2026	Aug 7, 2026	View filing
8-K	Aug 7, 2026	Aug 7, 2026	View filing
4	Aug 6, 2026	Aug 6, 2026	View filing
4	Aug 3, 2026	Aug 3, 2026	View filing
10-Q	Jul 31, 2026	Jul 31, 2026	View filing
8-K	Jul 30, 2026	Jul 30, 2026	View filing
3	Jul 29, 2026	Jul 29, 2026	View filing
4	Jul 2, 2026	Jul 2, 2026	View filing
4	Jul 2, 2026	Jul 2, 2026	View filing
4	Jun 25, 2026	Jun 25, 2026	View filing
4	Jun 23, 2026	Jun 23, 2026	View filing
3	Jun 23, 2026	Jun 23, 2026	View filing
8-K	Jun 23, 2026	Jun 23, 2026	View filing
4	Jun 9, 2026	Jun 9, 2026	View filing
4	Jun 4, 2026	Jun 4, 2026	View filing
4	Jun 1, 2026	Jun 1, 2026	View filing
4	Jun 1, 2026	Jun 1, 2026	View filing

SEC Filings

Recent Filings